CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

NCT00142103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis, Chronic Active

Interventions

DRUG: CPG10101
DRUG: CPG10101
DRUG: CPG10101
DRUG: CPG10101
DRUG: Control
DRUG: CPG10101

Sponsor

Pfizer